Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

A Pre-Game Routine Can Boost an Athlete's Performance: Study

NBA great Michael Jordan had a special ritual he would follow before every free throw: He would assume a shoulder-width stance, spin the basketball in...

Biotron Drug Effective Against COVID-19 In Animals

SYDNEY, Nov. 25, 2021. The Directors of Biotron Limited (ASX: BIT) are pleased to announce that the Company's lead clinical asset, BIT225, has demonstrated...

During the Holidays, Help Protect the Elderly from Falls

A holiday visit with older relatives might be a good chance to help them remove fall risks in their home, an expert suggests. Older adults' risk of falling...

Could a Single Dose of the HPV Vaccine Be Enough?

Women getting vaccinated against the cancer-causing human papillomavirus (HPV) now need two or three shots, but an African clinical trial suggests a single...

As Holidays Return to Normal, Here's How to De-Stress

A return to a more normal holiday season may also mean higher stress levels, so an expert offers some coping tips. Don't get too focused on buying the...

Give Others Help, Get Back Health Benefits: Study

When it comes to helping others and your health, it might be better to give than to receive, a new study suggests. Researchers surveyed more than 1,000...

Starpharma releases positive DEP phase 2 interim results in prostate cancer

MELBOURNE, Australia, Nov. 26, 2021. Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its...

A Routine Skin Check Could Save Your Life

It may sound dramatic, but skin checks save lives. While encouraging people to do routine self-exams, the American Academy of Dermatology (AAD) shares...

Merck and Ridgeback Biotherapeutics Provide Update on Results from MOVe-OUT Study of Molnupiravir, an Investigational Oral Antiviral Medicine, in At Risk Adults With Mild-to-Moderate COVID-19

(BUSINESS WIRE) November 26, 2021 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today provided...

Moderna Announces Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant

(BUSINESS WIRE)--Nov. 26, 2021-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today...

Read more news...

Recently Added

Recently added consumer and prescribing information: Lyvispah, Livtencity, Voxzogo, Besremi, Eprontia, Scemblix, Susvimo, Alprolix, Tyrvaya, Seglentis

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Livtencity Livtencity (maribavir) is a cytomegalovirus (CMV) pUL97 kinase inhibitor used for the treatment of post-transplant CMV infection/disease.
  • Fyarro Fyarro (sirolimus protein-bound particles) is an inhibitor of mechanistic target of rapamycin kinase (mTOR) for the treatment of malignant...
  • Voxzogo Voxzogo (vosoritide) is a C type natriuretic peptide (CNP) analog indicated to increase linear growth in pediatric patients with achondroplasia.

More FDA approvals